JAMDA
February 6, 2022
Showing 1 - 10 of 2188 results
Policy Snapshot
January 21, 2022
CMS Releases Latest Report on Antipsychotic Medication Use
The National Partnership to Improve Dementia Care in Nursing Homes has released its Antipsychotic Medicare Use and Data report for the second quarter of 2021. The Centers for Medicare & Medicaid Services (CMS) is tracking the progress of the National Partnership by reviewing publicly reported measures....
JAMDA
June 2, 2022
Impact of Nursing Home Factors on Antipsychotic Use in Residents Before and After the Implementation of the Antipsychotic Reduction Initiative: A Facility-level Analysis
JAMDA
November 21, 2018
Educating Nursing Home Staff in Dementia Sensitive Communication: Impact on Antipsychotic Medication Use
An educational program to enhance communication in nursing home dementia care increased person-centered communication by staff and resulted in reduced resident behavioral symptoms measured as resistiveness to care. The purpose of this analysis was to evaluate effects on resident antipsychotic medication us...
JAMDA
June 9, 2020
Policy to Reduce Antipsychotic Use and Hospitalization of Nursing Home Residents With Dementia
Following the 2012 launch of the National Partnership to Improve Dementia Care in Nursing Homes (the National Partnership), the use of antipsychotics has declined. However, little is known about the impact of this effort on quality of care and outcomes for nursing home (NH) residents with Alzheimer's ...
JAMDA
January 5, 2016
Physical Restraint and Antipsychotic Medication Use Among Nursing Home Residents With Dementia
To explore antipsychotic (AP) medications and physical restraint use and their effects on physical function and cognition in older nursing home residents.
JAMDA
February 27, 2016
Antipsychotic Drug Use Is Not Associated With Long-Term Mortality Risk in Norwegian Nursing Home Patients
To assess the long-term mortality risk associated with antipsychotic drug (AP) use in nursing homes.
Policy Snapshot
January 20, 2023
CMS to Increase Oversight of Antipsychotics Use
Last week, the U.S. Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), announced new actions to reduce the inappropriate use of antipsychotic medications and to bring greater transparency about nursing home citations to families.
JAMDA
September 20, 2019
Nursing Home Social Services and Post-Acute Care: Does More Qualified Staff Improve Behavioral Symptoms and Reduce Antipsychotic Drug Use?
An increasing number of post-acute care patients are admitted to skilled nursing facilities (SNFs) with behavioral symptoms such as wandering and rejecting care, which can interfere with care and place a patient at risk of social isolation or injury. This study examines whether increasing the qualification...
JAMDA
June 13, 2017